BioCentury
ARTICLE | Clinical News

Reticulose anti-viral: Will begin in February a Phase II/III trial

January 3, 1994 8:00 AM UTC

Advanced Viral Reasearch Corp. (ADVR), Miami Product: Reticulose anti-viral Indication: Treatment of hepatitis B and hepatitis C Status: Will begin in February a Phase II/III trial in Argentina in 20 ...